Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion type Assertion NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_head.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_provenance.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion evidence source_evidence_literature NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_provenance.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion SIO_000772 19642140 NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_provenance.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion wasDerivedFrom befree-20140225 NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_provenance.
- NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_assertion wasGeneratedBy ECO_0000203 NP854114.RA9QimhbHwyHw2sT1KQJ27nEllmCeqgs1h9OUO2xrvhy8130_provenance.